Peripheral Ischemia Fuels Breast Cancer Via Myeloid-Skewed Hematopoiesis [0.03%]
外周缺血通过髓系偏移的造血作用促进乳腺癌的发展
Pilar Martín
Pilar Martín
Ischemic Injury Drives Nascent Tumor Growth Via Accelerated Hematopoietic Aging [0.03%]
缺血损伤通过加速的造血老化驱动新生肿瘤生长
Alexandra A C Newman,José Gabriel Barcia Durán,Richard Von Itter et al.
Alexandra A C Newman et al.
Background: Patients with peripheral artery disease have an increased risk of cancer development. Aging-associated changes in hematopoietic stem and progenitor cells (HSPCs), including inflammation and increased myelopoie...
Cancer-Related Immune Therapies: Bidirectional Implications From Cardiotoxicity to Emerging Cardiovascular Therapeutics: JACC CardioOncology State-of-the-Art Review [0.03%]
肿瘤相关免疫治疗：从心脏毒性到新兴心血管治疗的双向影响：JACC心血管肿瘤学权威综述
Kapka Miteva,Markus S Anker,Henry Fechner et al.
Kapka Miteva et al.
Immune-based therapies-including immune checkpoint inhibitors, bispecific T cell engagers, chimeric antigen receptor T cells, and tumor-infiltrating lymphocytes- not only have transformed cancer treatment, but also have introduced significa...
Current Insights in Bidirectional Cardio-Oncology: Heart Failure Driving Cancer: JACC: CardioOncology Short-Form Primer [0.03%]
当前心癌联合医学的最新见解：心力衰竭与癌症：JACC心癌简明教程
Rudolf A de Boer,Laura I Yousif,Joseph Pierre Aboumsallem et al.
Rudolf A de Boer et al.
Cancer Development in Atherosclerotic Cardiovascular Disease: JACC: CardioOncology Short-Form Primer [0.03%]
动脉粥样硬化性心血管疾病中的癌症发生发展：JACC心内科肿瘤学简明教程
Jessie M Dalman,Kathryn J Moore
Jessie M Dalman
Managing Cardiovascular Risk in Clonal Hematopoiesis of Indeterminate Potential: JACC: CardioOncology Short-Form Primer [0.03%]
不确定潜能克隆性血液细胞增多症的心血管风险管理：JACC心血管肿瘤学简明指导
Ohad Oren,Aeron M Small,Amy E Lin et al.
Ohad Oren et al.
Clonal Hematopoiesis in Cancer and Cardiovascular Disease: JACC: CardioOncology State-of-the-Art Review [0.03%]
克隆性造血在癌症和心血管疾病中的作用：JACC心脏肿瘤学前沿综述
Megan A Evans,Kenneth Walsh
Megan A Evans
Emerging evidence suggests a dynamic relationship exists between cancer and cardiovascular disease (CVD). CVD is common among cancer survivors; however, it also may increase the risk of developing cancer. The underlying factors driving this...
Cancer and Cardiovascular Disease: Shared Risk Factors, Mechanisms, and Clinical Implications: JACC: CardioOncology State-of-the-Art Review [0.03%]
癌症与心血管疾病：共用危险因素、机制及临床意义：JACC心内科前沿综述
Laith Alhuneafat,Avirup Guha,Anne Blaes et al.
Laith Alhuneafat et al.
Cancer and cardiovascular disease (CVD) remain the leading causes of morbidity and mortality worldwide, with emerging evidence highlighting their complex and bidirectional interplay. Shared risk factors, including aging, systemic inflammati...
Cardiac Troponin Screening and Clinical Outcomes in Patients Receiving Immunotherapy [0.03%]
免疫治疗患者的肌钙蛋白筛查及临床转归
Evaline Cheng,Maja Ivanovic,Antonia Chan et al.
Evaline Cheng et al.
Background: Immune checkpoint inhibitors (ICIs) are associated with cardiotoxicities such as myocarditis. However, data on the implementation and outcomes of cardiac biomarker screening remain limited. ...
Anthracycline Dose, Myocardial Injury, and Change in Left Ventricular Function in the Cardiac CARE Trial [0.03%]
心脏CARE试验中蒽环类药物剂量、心肌损伤和左心室功能变化之间的关系
Krithika Loganath,Kuan Ken Lee,Olga Oikonomidou et al.
Krithika Loganath et al.
Background: Anthracycline-induced toxicity contributes to long-term cardiovascular morbidity in cancer survivors. Cardiac troponin is recommended for risk stratification and diagnosis, but the relationship between troponi...